期刊文献+

肺癌循环肿瘤细胞的单细胞EGFR基因突变检测 被引量:8

Single-cell detection of EGFR gene mutation in circulating tumor cells in lung cancer
下载PDF
导出
摘要 循环肿瘤细胞(Circulating tumor cells,CTCs)是从肿瘤原发病灶脱落并侵入外周血循环的肿瘤细胞。由于CTCs存在较大的异质性,其与癌症发展转移密切相关,但目前尚缺乏有效的CTCs单细胞异质性检测方法。鉴于此,本文发展了在单细胞层面对CTCs进行基因突变的检测方法并用于单个肺癌CTC的EGFR(Epidermal growth factor receptor)基因突变检测。首先用集成式微流控系统完成血液中稀有CTCs的捕获,接着将CTCs释放入含有多个微孔的微阵列芯片中,得到含有单个CTC的微孔,通过显微操作将单个CTC转入PCR管内完成单细胞基因组的放大,并进行单细胞的EGFR基因突变检测。以非小细胞肺癌细胞系A549、NCI-H1650和NCI-H1975为样本,通过芯片与毛细管修饰、引物扩增条件(复性温度、循环次数)的优化,结果显示在复性温度59℃、30个循环次数的条件下,引物扩增效果最优。利用该方法成功地对非小细胞肺癌(Non-small cell lung cancer,NSCLC)患者的血液样本进行了测试。从患者2 m L血液中获取5个CTCs,分别对其EGFR基因的第18、19、20、21外显子进行测序,发现该患者CTCs均为EGFR野生型。研究结果证明此检测方法可以灵敏地用于单个CTC基因突变的检测,在临床研究上具有重要的指导意义。 Circulating tumor cells(CTCs) are cells that shed from a primary tumor and enter the peripheral blood circulation. The CTCs are closely associated with tumor development and metastasis because of its high heterogeneity. However, there are still no effective methods to detect single-cell heterogeneity of the CTCs. To this end, we developed a method to detect gene mutation in CTCs at the single-cell level and applied it to the detection of EGFR gene mutation in single lung cancer CTC. Specifically, the rare CTCs were captured from blood using an integrated microfluidic system, and then were released into a microchip with thousands of nanoliter wells to isolate single CTC. The single CTC was then transferred into a PCR tube under the microscope for single-cell genome amplification and detection of EGFR gene mutation. We firstly modified chip and capillary and optimized PCR conditions(annealing temperature, number of cycles) using non-small-cell lung cancer(NSCLC) cell lines A549, NCI-H1650 and NCI-H1975 as samples, which showed maximal amplification after 30 cycles with an annealing temperature at 59℃. We then successfully detected blood samples from NSCLC patients using this method. 5 CTCs were obtained from 2 m L patient's blood and the sequencing of EGFR exons 18, 19, 20 and 21 showed no mutations. Our results demonstrated that this method is sensitive enough to detect gene mutation in single CTC and has guiding significance in clinic research.
作者 孙帅 邓宇亮
机构地区 上海交通大学
出处 《遗传》 CAS CSCD 北大核心 2015年第12期1251-1257,共7页 Hereditas(Beijing)
基金 国家自然科学基金项目(编号:21205077) 上海市自然科学基金项目(编号:13ZR1456100) 教育部博士点基金(编号:20130073120106)资助
关键词 循环肿瘤细胞 微流控芯片 单细胞基因突变检测 EGFR circulating tumor cells microfluidic chip single-cell gene mutation EGFR
  • 相关文献

参考文献23

  • 1Paz-Ares L, de Marinis F, Dediu M, Thomas M, Pujol JL, Bidoli P, Molinier O, Sahoo TP, Laack E, Reck M, Corral J, Melemed S, John W, Chouaki N, ZimmermannAH, Visse- ren-Grul C, Gridelli C. Maintenance therapy with peme- trexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial. Lancet Oncol, 2012, 13(3): 247-255.
  • 2Goto K, Satouchi M, Ishii G, Nishio K, Hagiwara K, Mit- sudomi T, Whiteley J, Donald E, McCormack R, Todo T. An evaluation study of EGFRmutation tests utilized for non-small-cell lung cancer in the diagnostic setting. Ann Oncol, 2012, 23(11): 2914-2919.
  • 3Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, Collura CV, Inserra E, Diederichs S, Iafrate A J, Bell DW, Digumarthy S, Muzikansky A, lrimia D, Settleman J, Tompkins RG, Lynch T J, Toner M, Haber DA. Detection of mutations in EGFRin circulating lung-cancer cells. N Engl JMed, 2008, 359(4): 366 377.
  • 4Oxnard GR, Paweletz CP, Kuang YN, Maeh SL, O'ConnellA, Messineo MM, Luke Jl, Butaney M, Kirschmeier P, Jackman DM, J/inne PA. Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantita- tive next-generation genotyping of cell-free plasma DNA. Clin Cancer Res, 2014, 20(6): 1698-1705.
  • 5Wang Z J, Chen R, Wang SH, Zhong J, Wu MN, Zhao J, Duan JC, Zhuo ML, An TT, Wang YY, Bai H, Wang J. Quantification and dynamic monitoring ofEGFR T790M in plasma cell-free DNA by digital PCR for prognosis of EGFR-TKI treatment in advanced NSCLC. PLoS One, 2014, 9(11): el 10780.
  • 6李海静,刘岩,郝海生,杜卫华,赵学明,王栋,秦彤,马友记,朱化彬.表皮生长因子受体与肺脏发育的关系[J].遗传,2012,34(1):27-32. 被引量:6
  • 7den Toonder J. Circulating tumor cells: the Grand Chal- lenge. Lab Chip, 2011, 11(3): 375-377.
  • 8Wang ST, Wang H, Jiao J, Chen KJ, Owens GE, Kamei K, Sun J, Sherman DJ, Behrenbruch CP, Wu H, Tseng HR. Three-dimensional nanostructured substrates toward effi- cient capture of circulating tumor cells. Angew Chem Int Ed, 2009, 48(47): 8970-8973.
  • 9林炳承.微流控芯片实验室及其功能化[J].中国药科大学学报,2003,34(1):1-6. 被引量:39
  • 10Sun J, Masterman-Smith MD, Graham NA, Jiao J, Motta- hedeh J, Laks DR, Ohashi M, De Jesus J, Kamei K, Lee KB, Wang H, Yu ZTF, Lu YT, Hou S, Li KY, Liu M, Zhang NG, Wang ST, Angenieux B, Panosyan E, Samuels ER, Park J, Williams D, Konkankit V, Nathanson D, Van Dam RM, Phelps ME, Wu H, Liau LM, Mischel PS, La- zareff JA, Kornblum HI, Yong WH, Graeber TG, Tseng HR. A microfluidic platform for systems pathology: mul- tiparameter single-cell signaling measurements of clini- cal brain tumor specimens. Cancer Res, 2010, 70(15): 6128-6138.

二级参考文献153

共引文献55

同被引文献57

引证文献8

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部